Microbial transformation of the phthalideisoquinoline alkaloid, (-)-beta-hydrastine.
W H M W Herath, D Ferreira, I A Khan
Index: Nat. Prod. Res. 17(4) , 269-74, (2003)
Full Text: HTML
Abstract
The phthalideisoquinoline alkaloid (-)-beta-hydrastine is one of the main active constituents of the medicinal plant, Hydrastis canadensis, which is used in many dietary supplements intended to enhance the immune system. Treatment of hydrastine with the fermentation broth of Polyporous brumalis (ATCC 34487) as a model for mammalian metabolism, gave a new alkaloid, (1S)-hydroxyhydrastine. Structure elucidation was based primarily on NMR and chiroptical studies.
Related Compounds
Related Articles:
Expanding the repertoire of small molecule transcriptional activation domains.
2009-02-01
[Bioorg. Med. Chem. 17 , 1034-43, (2009)]
2001-11-01
[J. Neurophysiol. 86(5) , 2363-73, (2001)]
Effects of (1R,9S)-beta-hydrastine on l-DOPA-induced cytotoxicity in PC12 cells.
2004-03-19
[Eur. J. Pharmacol. 488(1-3) , 71-7, (2004)]
2008-01-01
[J. AOAC Int. 91(4) , 694-701, (2008)]
Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells.
2001-10-01
[Planta Med. 67 , 609-613, (2001)]